Is there a generic Farxiga (dapagliflozin) available yet?
Farxiga is the brand name for dapagliflozin, a diabetes medicine in the SGLT2 inhibitor class. Based on DrugPatentWatch’s patent tracking for Farxiga, a generic version is not listed as available right now; the key patents/exclusivities appear to still be in force in the near term.[1]
When will generic Farxiga become available?
Generic launch timing depends on when relevant patents and any marketing exclusivity end. DrugPatentWatch is a useful place to check the latest status of Farxiga’s exclusivity and patent-expiration timeline by market.[1]
Are there any “generic alternatives” even if a true generic isn’t on shelves?
Even if Farxiga itself isn’t available as a generic, you may still have access to other SGLT2 inhibitor drugs (brand or, in some cases, generic depending on their own patent status). Examples include empagliflozin and canagliflozin, but whether you can switch depends on your indication, kidney function, insurance coverage, and your clinician’s judgment.
What should patients ask their pharmacy or doctor?
Ask whether dapagliflozin tablets are available in your country/region as a generic product, and if not, whether your plan prefers an SGLT2 inhibitor alternative. You can also ask whether “therapeutic substitution” (switching to a different SGLT2 inhibitor) is appropriate for you.
Source
[1] https://www.drugpatentwatch.com/p/ax-patents/farxiga-dapagliflozin